- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coloplast A/S Class B (COLOb)
The Coloplast B share price today is 424.5, view CSE COLOb stock exchange data. Track the latest Coloplast B share price with real-time updates on COLOb stock performance including market cap, day range, 52-week range and dividend yield. Access COLOb charts, earnings dates and analyst estimates to support your investment decisions.
424.5
-1.8(-0.42%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
421.3
428.3
52 wk Range
369.7
631.4
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
421.3428.3
52 wk Range
369.7631.4
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COLOb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
465.2
Upside
+9.59%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Why is Coloplast stock sliding today?- Investing.com
COLOPLAST -B- receives Investment Bank Analyst Rating Update- Investing.com
Pro
- COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
15 Hold
3 Sell
Ratings:
21 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 465.2
(+9.59% Upside)
Earnings
Latest Release
18-08-2026
EPS / Forecast
6.55 / 6.19
Revenue / Forecast
7.36B / 7.27B
Compare COLOb to Peers and Sector
Metrics to compare | COLOb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOLObPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.7x | 22.2x | −0.3x | |
PEG Ratio | −1.08 | −0.05 | 0.00 | |
Price/Book | 7.2x | 2.2x | 2.6x | |
Price / LTM Sales | 3.4x | 2.6x | 3.0x | |
Upside (Analyst Target) | 9.1% | 0.0% | 57.9% | |
Fair Value Upside | Unlock | 23.2% | 7.6% | Unlock |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Coloplast B (COLOb) Share Price Today?
The Coloplast B share price today is 424.5.
What is the current Coloplast B (COLOb) share price and day range?
As of 08-10-2026, the Coloplast B share price is 424.5, with a previous close of 426.3. The share price has ranged from 421.3 to 428.3 today, while the 52-week range spans from 369.7 to 631.4.
What Is the Coloplast B Market Cap?
As of today, Coloplast B market cap is 95.31B.
Does Coloplast B Pay Dividends? What's The Current Dividend Yield?
The Coloplast B dividend yield is 5.4%.
What Is the Coloplast B (COLOb) Share Price Target?
The average 12-month share price target for Coloplast B is 465.2, with a high estimate of 625 and a low estimate of 377. 3 analysts recommend buying, while 3 suggest selling, with an overall rating of Neutral and +9.59% Upside potential.
What Is Coloplast B's Earnings Per Share (TTM)?
The Coloplast B EPS (TTM) is 12.3.
When Is the Next Coloplast B Earnings Date?
Coloplast B will release its next earnings report on 03-11-2026.
From a Technical Analysis Perspective, Is COLOb a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Coloplast B Trade On?
Coloplast B is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for Coloplast B?
The stock symbol for Coloplast B is "COLOb."
How Many Times Has Coloplast B Stock Split?
Coloplast B has split 5 times.
How Many Employees Does Coloplast B Have?
Coloplast B has 17213 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.